Center City’s Lia Diagnostics, makers of a flushable pregnancy test, just took on $2.6 million in venture capital as it continues to work on bringing the test to the consumer market.
CEO and cofounder Bethany Edwards declined to comment on specific terms of the round, but she confirmed that investors included past backers of the startup (like Ben Franklin Technology Partners and Robin Hood Ventures) plus Raleigh-based Pink Ceiling.
The North Carolina investment and advisory firm was founded in 2016 by Cindy Eckert, a two-time founder of pharmaceutical companies (most notably “female Viagra” maker Sprout Pharmaceuticals).
LIA, founded in 2015, is an alumni of Dreamit’s accelerator program as well as the University City Science Center’s Digital Health Accelerator. Last December it received a 510(k) clearance from the U.S. Food and Drug Administration for over-the-counter sale of its pregnancy test, and took home a $50,000 prize at TechCrunch Disrupt Berlin.
Emails and calls to investors were not immediately returned.
HealthVerity plans big growth spurt with $25M Series C
South Philly agtech startup Augean Robotics raises $1.5M
The City just launched a new grant program for underrepresented tech founders
Why Deacom’s team prioritizes collaboration and continuous improvement
Josh Kopelman revealed as investor in Backstage Capital’s accelerator
Report: Backstage Capital shifts focus to accelerator, lays off staffers
Comcast’s LIFT Labs is launching a new meetup group for female founders and funders
Engineers have Vistar Media’s Philly office all to themselves
Sign-up for daily news updates from Technical.ly Philadelphia